论文部分内容阅读
Hepatitis C virus(HCV) which was originally recognized as posttransfusion non-A, non-B hepatitis has been amajor global health problem affecting 3% of the world population. Interferon/peginterferon and ribavirin combination therapy was the backbone of chr